These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26852745)

  • 1. Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.
    Kervezee L; Stevens J; Birkhoff W; Kamerling IM; de Boer T; Dröge M; Meijer JH; Burggraaf J
    Br J Clin Pharmacol; 2016 Feb; 81(2):256-68. PubMed ID: 26852745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and dose optimization of levofloxacin in elderly patients with pneumonia.
    He YY; Sun J; Wu YE; Wang YB; van den Anker J; Hao GX; Sun DQ; Zhao W
    Br J Clin Pharmacol; 2024 May; 90(5):1213-1221. PubMed ID: 38317382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of oral levofloxacin in healthy volunteers and dosing optimization for multidrug-resistant tuberculosis therapy.
    Boonpeng A; Jaruratanasirikul S; Wattanavijitkul T; Nawakitrangsan M; Samaeng M
    Biopharm Drug Dispos; 2021 Jul; 42(7):329-337. PubMed ID: 34117648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.
    Aboubakr M; Uney K; Elmas M
    Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of levofloxacin after single intravenous, oral and subcutaneous administration to dogs.
    Landoni MF; Albarellos GA
    J Vet Pharmacol Ther; 2019 Mar; 42(2):171-178. PubMed ID: 30302775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of levofloxacin following oral administration of a generic levofloxacin tablet and intravenous administration to dogs.
    Madsen M; Messenger K; Papich MG
    Am J Vet Res; 2019 Oct; 80(10):957-962. PubMed ID: 31556716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2014 Aug; 53(8):753-62. PubMed ID: 24989061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
    Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of a pharmacokinetic interaction between digoxin and levofloxacin.
    Chien SC; Rogge MC; Williams RR; Natarajan J; Wong F; Chow AT
    J Clin Pharm Ther; 2002 Feb; 27(1):7-12. PubMed ID: 11846857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of levofloxacin in Korean patients.
    Kiem S; Ryu SM; Lee YM; Schentag JJ; Kim YW; Kim HK; Jang HJ; Joo YD; Jin K; Shin JG; Ghim JL
    J Chemother; 2016 Aug; 28(4):308-13. PubMed ID: 25976699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
    Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of levofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Ambros LA; Landoni MF
    J Vet Pharmacol Ther; 2005 Aug; 28(4):363-9. PubMed ID: 16050816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of oral levofloxacin 500 mg once-daily dosage in community-acquired lower respiratory tract infections: results of a prospective multicenter study in China.
    Zhang J; Xu JF; Liu YB; Xiao ZK; Huang JA; Si B; Sun SH; Xia QM; Wu XJ; Cao GY; Shi YG; Zhang YY
    J Infect Chemother; 2009 Oct; 15(5):293-300. PubMed ID: 19856067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a dosing-adjustment tool for fluoroquinolones in osteoarticular infections: The Fluo-pop study.
    Lemaitre F; Fily F; Foulquier JB; Revest M; Jullien V; Petitcollin A; Tattevin P; Tron C; Polard JL; Verdier MC; Comets E; Huten D; Arvieux C; Bellissant E; Laviolle B
    Biomed Pharmacother; 2021 Oct; 142():112053. PubMed ID: 34435591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation.
    Hussein Z; Mukherjee D; Lamm J; Cavanaugh JH; Granneman GR
    J Clin Pharmacol; 1994 Jul; 34(7):754-9. PubMed ID: 7929870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration.
    Kervezee L; Gotta V; Stevens J; Birkhoff W; Kamerling I; Danhof M; Meijer JH; Burggraaf J
    CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):466-74. PubMed ID: 27479699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, urinary excretion and dosage regimen of levofloxacin following a single intramuscular administration in cross bred calves.
    Dumka VK; Srivastava AK
    J Vet Sci; 2006 Dec; 7(4):333-7. PubMed ID: 17106223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Critical Illness Change Levofloxacin Pharmacokinetics?
    Roberts JA; Cotta MO; Cojutti P; Lugano M; Della Rocca G; Pea F
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1459-63. PubMed ID: 26666946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.